CD155 in tumor progression and targeted therapy.
暂无分享,去创建一个
Ligong Lu | Xian-Yang Li | Meixiao Zhan | Yuncong Zhang | Tianqing Liu | Zhiren Zhang | Xiaoguang Zhao
暂无分享,去创建一个
Ligong Lu | Xian-Yang Li | Meixiao Zhan | Yuncong Zhang | Tianqing Liu | Zhiren Zhang | Xiaoguang Zhao